UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): June 9, 2006
REGENERON PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| New York
|
|
000-19034
|
|
133444607 |
|
|
|
|
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification Number) |
| |
|
|
| 777 Old Saw Mill River Road, Tarrytown, New York
|
|
10591-6707 |
| |
| (Address of principal executive offices)
|
|
(Zip Code) |
(914) 347-7000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of registrant under any of the following provisions:
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events
On June 9, 2006, the Company presented the slides included as
Exhibit 99(a) to this Current Report on Form 8-K at its Annual
Meeting of Shareholders held at the Westchester Marriott Hotel,
670 White Plains Road, Tarrytown, New York. A copy of the slide
presentation is also available on the Company’s website at
www.regneron.com.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
99(a) Slides presented at the Company’s 2006 Annual Meeting of
Shareholders held on June 9, 2006.
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
REGENERON PHARMACEUTICALS, INC.
|
|
| Dated: June 9, 2006 |
By: |
/s/ Stuart Kolinski
|
|
| |
|
Stuart Kolinski |
|
| |
|
Vice President and General Counsel |
|
2